Nemanja damjanov biography
•
Biologics, cardiovascular effects and cancer
- Commentary
- Open access
- Published:
BMC Medicinevolume 12, Article number: 48 () Cite this article
Accesses
6 Altmetric
Metrics details
Abstract
Rheumatoid arthritis (RA) is associated with increased cardiovascular risk. Treatment with tumor necrosis factor (TNF)-inhibitors leads to about a 50% reduction in the first cardiovascular event. TNF-inhibitors could transiently improve flow-mediated vasodilation and improve carotid intima-media thickness (ccIMT) during the treatment of RA. Treatment with TNF-inhibitors is associated with an increased total cholesterol (TC) and HDL-cholesterol (HDLc) level, without sustained change of the atherogenic index. The overall cancer risk in RA patients is comparable to that of the general population, but patients with RA slightly more often have lymphomas and lung tumors, and less often have colorectal and breast tumors in comparison to the general population. In randomized
•
Ultrasound guided injection with Collagen-based Medical Device: real-life evaluation of efficacy and safety in hip osteoarthritis
Aims: Data regarding the treatment of hip osteoarthritis (OA) with collagen-based extracellular bio-scaffolds are lacking. We evaluated the treatment of hip OA with ultrasound guided intraarticular injections of Collagen-based Medical Device (CMD).
Material and methods: Forty-four patients with Kellgren-Lawrence grade (KLG) I or II were selected, and 20/44 randomly selected patients (CMD group), were treated with 2 weekly consecutive ultrasound guided intraarticular injections of CMD (MD-HIP, Guna S.p.a. Milan, Italy). An additional 24/44 patients were treated with oral non-steroidal anti-inflammatory drugs (NSAIDs) daily (NSAIDs group). Clinical assessment, X-rays and ultrasound evaluation were performed at baseline, and after 1 month in both groups, and after 3 months in the CMD group. Outcome measures were general pain VAS (), the whole WO
•
Prof. Dr. Nemanja Damjanov, subspecialist in rheumatology at Moj Lab polyclinic
Doctor Damjanov built his year long career at the Institute of Rheumatology in Belgrade, starting from the position of clinical physician, to the position of director of the Institute and professor at the Department of Internal Medicine.
Prof. Dr. Nemanja Damjanov fryst vatten the author and co-author of over papers. Among the many studies in which he participated, there is one that proved the effectiveness and safety of the Orthokin method in the treatment of chronic shoulder pain.
He fryst vatten a member, founder and secretary of EULAR (European League Against Rheumatism) and president of URESA (Association of Rheumatologists of Serbia).
Take advantage of the opportunity to be examined bygd this renowned expert supported by the most modern equipment available at the Moj Lab polyclinic.
Schedule an inspection bygd calling the number
NewsNemanja DamjanovMy LabPolyclinic Moj Lab